Troponin I test demonstrates breakthrough performance

2 April 2024

The Quidel TriageTrue® High Sensitivity Troponin I Test was the only point-of-care (POC) included in the European Society of Cardiology guideline for the 0–1 hour algorithm protocol, with 74% of patients assigned to rule out or rule in zones within one hour, on par with top central lab assays. Dr. Ahmed Dakshi, a cardiology research fellow and principal investigator for the MACRO-2 trial, discusses the study and how he assessed the analytical and clinical performance of this latest POC offering from QuidelOrtho.